|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
|
DE3377363D1
(en)
|
1982-03-31 |
1988-08-18 |
Ajinomoto Kk |
Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
|
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
|
US4892743A
(en)
|
1983-12-21 |
1990-01-09 |
Schering Corporation |
Novel hybrid interferon species
|
|
WO1985002862A1
(en)
|
1983-12-23 |
1985-07-04 |
Monash University |
PRODUCTION OF HUMAN INTERFERON-alpha
|
|
AU594014B2
(en)
|
1984-03-21 |
1990-03-01 |
Research Corporation Technologies, Inc. |
Recombinant DNA molecules
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
JPS63500636A
(ja)
|
1985-08-23 |
1988-03-10 |
麒麟麦酒株式会社 |
多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
|
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
AU639428B2
(en)
|
1988-12-01 |
1993-07-29 |
Imclone Systems, Inc. |
Synthetic interleukin-6
|
|
US5225337A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Ribozyme compositions and methods for use
|
|
US5246921A
(en)
|
1990-06-26 |
1993-09-21 |
The Wistar Institute Of Anatomy And Biology |
Method for treating leukemias
|
|
US5780036A
(en)
|
1991-08-26 |
1998-07-14 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
|
|
ATE227118T1
(de)
|
1993-08-02 |
2002-11-15 |
Scripps Research Inst |
Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
|
|
SE9401709D0
(sv)
*
|
1994-05-18 |
1994-05-18 |
Mathilda Sjoeberg |
Improved alphavirus vectors for expression of heterologous DNA
|
|
US5792462A
(en)
|
1995-05-23 |
1998-08-11 |
University Of North Carolina At Chapel Hill |
Alphavirus RNA replicon systems
|
|
US6041252A
(en)
|
1995-06-07 |
2000-03-21 |
Ichor Medical Systems Inc. |
Drug delivery system and method
|
|
DE19712889A1
(de)
|
1997-03-27 |
1998-10-01 |
Bosch Gmbh Robert |
Verfahren und Vorrichtung zur Ermittlung einer den Systemdruck in einem Bremskreis beschreibenden Größe
|
|
NZ337853A
(en)
|
1997-04-03 |
2002-03-28 |
Electrofect As |
Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
US5873849A
(en)
|
1997-04-24 |
1999-02-23 |
Ichor Medical Systems, Inc. |
Electrodes and electrode arrays for generating electroporation inducing electrical fields
|
|
GB0023203D0
(en)
|
2000-09-21 |
2000-11-01 |
Isis Innovation |
Vaccination method
|
|
US6117660A
(en)
|
1997-06-10 |
2000-09-12 |
Cytopulse Sciences, Inc. |
Method and apparatus for treating materials with electrical fields having varying orientations
|
|
WO1999001158A1
(fr)
|
1997-06-30 |
1999-01-14 |
Rhone-Poulenc Rorer S.A. |
Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
|
|
US5958060A
(en)
|
1998-01-02 |
1999-09-28 |
General Electric Company |
Method and apparatus for clock control and synchronization
|
|
US20020164585A1
(en)
*
|
1998-01-16 |
2002-11-07 |
Sean Chapman |
Method for enhancing RNA or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
|
|
EP2428250A1
(en)
|
1998-07-13 |
2012-03-14 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
US6319901B1
(en)
|
1998-10-15 |
2001-11-20 |
Ichor Medical Systems, Inc. |
Methods for prolonging cell membrane permeability
|
|
AU6235000A
(en)
*
|
1999-07-21 |
2001-02-13 |
Large Scale Biology Corporation |
Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
|
|
US20040213805A1
(en)
|
1999-10-12 |
2004-10-28 |
Verheije Monique Helene |
Deletions in arterivirus replicons
|
|
US6982087B2
(en)
|
2000-09-07 |
2006-01-03 |
The University Of North Carolina At Chapel Hill |
Vectors derived from South African Arbovirus No. 86
|
|
US6538922B1
(en)
|
2000-09-27 |
2003-03-25 |
Sandisk Corporation |
Writable tracking cells
|
|
EP1195438A1
(en)
*
|
2000-10-06 |
2002-04-10 |
Rijksuniversiteit te Groningen |
Genetic immunisation against cervical carcinoma
|
|
NZ524661A
(en)
|
2000-11-23 |
2005-03-24 |
Bavarian Nordic As |
Modified vaccinia ankara virus variant
|
|
AU2002242016A1
(en)
|
2001-02-01 |
2002-08-12 |
The Johns Hopkins University |
Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
|
|
EP1397498A1
(en)
|
2001-05-21 |
2004-03-17 |
ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. |
Delections in arterivirus replicons
|
|
EP1278382B1
(en)
|
2001-07-19 |
2007-02-14 |
Telefonaktiebolaget LM Ericsson (publ) |
Method and apparatus for solving number portability in origin
|
|
US7204997B2
(en)
|
2002-01-29 |
2007-04-17 |
Supratek Pharma Inc. |
Responsive microgel and methods related thereto
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US6912417B1
(en)
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
|
AU2003297860A1
(en)
*
|
2002-12-12 |
2004-07-09 |
The Board Of Regents Of The University Of Texas System |
Large scale production of packaged alphavirus replicons
|
|
EP1593738A4
(en)
*
|
2003-01-30 |
2006-05-31 |
Shanghai Tengen Biomedical Co |
VIRUSELY PARTICULATE VACCINE WITH RECOMBINANT DENGUEVIRUS REPLICANT AS ITS SUPPORT
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
ATE432285T1
(de)
|
2003-07-11 |
2009-06-15 |
Alphavax Inc |
Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
|
|
WO2005026316A2
(en)
*
|
2003-09-15 |
2005-03-24 |
Bioption Ab |
Alphavirus vaccines
|
|
US20050070700A1
(en)
|
2003-09-30 |
2005-03-31 |
Matthias Giese |
Equine arteritis virus vaccine
|
|
US20050171044A1
(en)
*
|
2003-12-24 |
2005-08-04 |
Stein David A. |
Oligonucleotide compound and method for treating nidovirus infections
|
|
ES2542139T3
(es)
|
2004-03-08 |
2015-07-31 |
Ichor Medical Systems Inc. |
Aparato mejorado para el suministro, mediado eléctricamente, de agentes terapéuticos
|
|
DK1751289T3
(da)
|
2004-05-18 |
2009-05-11 |
Alphavax Inc |
TC-83-afledte alfavirus-vektorer, partikler og fremgangsmåder
|
|
KR100872840B1
(ko)
*
|
2004-07-09 |
2008-12-22 |
(주)씨아이디 |
돼지생식기호흡기증후군 바이러스에 대한 전체-길이의감염성이 있는 cDNA 클론 및 이의 용도
|
|
US7862829B2
(en)
*
|
2004-07-09 |
2011-01-04 |
University Of North Carolina At Chapel Hill |
Viral adjuvants
|
|
EP2357000A1
(en)
|
2005-10-18 |
2011-08-17 |
Novartis Vaccines and Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
|
EP1792996A1
(en)
*
|
2005-12-01 |
2007-06-06 |
Consejo Superior de Investigaciones Cientificas |
Nucleic acid sequences encoding vaccines against Porcine reproductive and respiratory syndrome virus (PRRSV)
|
|
CA2655175A1
(en)
|
2006-06-06 |
2007-12-13 |
Melbourne Health |
Detection and use of antiviral resistance mutations
|
|
US20120121650A1
(en)
|
2006-08-18 |
2012-05-17 |
Johnston Robert E |
Chimeric Virus Vaccines
|
|
PT3524316T
(pt)
|
2006-10-17 |
2024-11-29 |
Inovio Pharmaceuticals Inc |
Dispositivos de eletroporação para eletroporação de células em mamíferos
|
|
WO2008073303A2
(en)
|
2006-12-07 |
2008-06-19 |
Switchgear Genomics |
Transcriptional regulatory elements of biological pathways, tools, and methods
|
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Ｈｂｖ 백신 및 그의 제조 방법
|
|
JP5602624B2
(ja)
|
2007-06-21 |
2014-10-08 |
アルファバックス， インコーポレイテッド |
αウイルス構造タンパク質の発現のためのプロモーターレスカセット
|
|
US20110110974A1
(en)
|
2007-10-29 |
2011-05-12 |
Erik Depla |
Methods and kits for inducing a ctl response using a prime boost regimen
|
|
EP2451475A2
(en)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Self replicating rna molecules and uses thereof
|
|
RU2555346C2
(ru)
|
2009-08-07 |
2015-07-10 |
Трансген Са |
Композиция для лечения инфекции вирусом гепатита в
|
|
ES2647662T3
(es)
*
|
2009-12-31 |
2017-12-26 |
Medigen, Inc. |
Vacunas de ADN infeccioso frente al virus chikungunya
|
|
SI3243526T1
(sl)
|
2010-07-06 |
2020-02-28 |
Glaxosmithkline Biologicals S.A. |
Dostava RNA za sprožitev večih imunskih poti
|
|
CA2822462A1
(en)
|
2010-12-20 |
2012-06-28 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
EA032364B1
(ru)
|
2011-02-11 |
2019-05-31 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
|
|
KR102081868B1
(ko)
|
2011-06-28 |
2020-02-26 |
이노비오 파마수티컬즈, 인크. |
최소 침습 피부 전기천공 장치
|
|
TWI623618B
(zh)
|
2011-07-12 |
2018-05-11 |
傳斯堅公司 |
Ｈｂｖ聚合酶突變體
|
|
WO2013120499A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
|
|
EP2814962B1
(en)
*
|
2012-02-15 |
2018-07-04 |
CureVac AG |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
|
|
US8961995B2
(en)
*
|
2012-09-20 |
2015-02-24 |
Uab Research Foundation |
Methods and compositions for alphavirus replicons
|
|
EP3178505B1
(en)
|
2012-12-13 |
2018-05-02 |
Panasonic Healthcare Holdings Co., Ltd. |
Medicament injection device
|
|
WO2014170493A2
(en)
|
2013-04-19 |
2014-10-23 |
Novartis Ag |
Alphavirus vector
|
|
WO2015024669A1
(en)
|
2013-08-21 |
2015-02-26 |
Curevac Gmbh |
Combination vaccine
|
|
US20170151339A1
(en)
|
2014-06-30 |
2017-06-01 |
Tarveda Therapeutics, Inc. |
Targeted conjugates and particles and formulations thereof
|
|
WO2016020538A1
(en)
|
2014-08-08 |
2016-02-11 |
Transgene Sa |
Hbv vaccine and antibody combination therapy to treat hbv infections
|
|
KR102586707B1
(ko)
|
2014-10-01 |
2023-10-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
항원 및 어쥬번트로서 인터류킨-21을 갖는 백신
|
|
HRP20220893T1
(hr)
*
|
2015-04-08 |
2022-10-14 |
Novartis Ag |
Cd20 terapije, cd22 terapije, i kombinirane terapije sa stanicom koja eksprimira cd19 kimerni antigenski receptor
|
|
US11559570B2
(en)
|
2015-05-15 |
2023-01-24 |
CureVac SE |
Prime-boost regimens involving administration of at least one mRNA construct
|
|
US10550164B2
(en)
|
2015-08-03 |
2020-02-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use
|
|
KR102535764B1
(ko)
|
2016-03-28 |
2023-05-30 |
아이커 메디칼 시스템스 인코포레이티드 |
치료제를 전달하기 위한 장치
|
|
EP3439696A4
(en)
|
2016-04-06 |
2019-12-25 |
University of Washington |
THERAPEUTIC VACCINE AGAINST THE HEPATITIS B VIRUS (HBV) USING THE HBV CORE ANTIGEN
|
|
AU2017249424B2
(en)
|
2016-04-13 |
2023-08-24 |
Janssen Pharmaceuticals, Inc. |
Recombinant arterivirus replicon systems and uses thereof
|
|
CN110073002B
(zh)
|
2016-10-17 |
2024-06-11 |
杨森制药公司 |
重组病毒复制子体系及其用途
|
|
MX2019006467A
(es)
|
2016-12-05 |
2019-12-09 |
Janssen Pharmaceuticals Inc Star |
Composiciones y métodos para mejorar la expresión génica.
|
|
CN110612118B
(zh)
|
2017-06-05 |
2024-02-13 |
比科尔公司 |
用于引起针对hbv的免疫应答的病毒样粒子
|
|
CN111542340B
(zh)
|
2017-11-16 |
2023-12-19 |
华盛顿大学 |
治疗性乙型肝炎病毒(hbv)疫苗
|
|
US11021692B2
(en)
|
2017-12-19 |
2021-06-01 |
Janssen Sciences Ireland Unlimited Company |
Hepatitis B virus (HBV) vaccines and uses thereof
|
|
MX2020006480A
(es)
|
2017-12-19 |
2020-09-22 |
Janssen Sciences Ireland Unlimited Co |
Vacunas contra el virus de la hepatitis b (hbv) y usos de las mismas.
|